Lisa E. Ranshaw

479 total citations
10 papers, 334 citations indexed

About

Lisa E. Ranshaw is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Lisa E. Ranshaw has authored 10 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Physiology. Recurrent topics in Lisa E. Ranshaw's work include Phosphodiesterase function and regulation (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Asthma and respiratory diseases (3 papers). Lisa E. Ranshaw is often cited by papers focused on Phosphodiesterase function and regulation (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Asthma and respiratory diseases (3 papers). Lisa E. Ranshaw collaborates with scholars based in United Kingdom, Netherlands and Norway. Lisa E. Ranshaw's co-authors include Cathy Tralau-Stewart, Anthony T. Nials, Joanne Wiseman, Richard G. Knowles, Fiona S. Lucas, Yemisi Solanke, John A. Dawson, Don O. Somers, Stuart P. Ballantine and Malcolm R. Clench and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Analytical and Bioanalytical Chemistry and Drug Metabolism and Disposition.

In The Last Decade

Lisa E. Ranshaw

9 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa E. Ranshaw United Kingdom	8	183	117	69	69	44	10	334
Bradley Condon United States	7	159 0.9×	90 0.8×	57 0.8×	38 0.6×	13 0.3×	8	381
Michael J. Ashton United Kingdom	11	236 1.3×	135 1.2×	81 1.2×	57 0.8×	16 0.4×	19	409
Clint D. W. Brooks United States	9	100 0.5×	139 1.2×	86 1.2×	40 0.6×	13 0.3×	17	298
Fuk‐Wah Sum United States	11	214 1.2×	271 2.3×	51 0.7×	20 0.3×	53 1.2×	13	485
Zhengxiang Gu United States	11	232 1.3×	327 2.8×	72 1.0×	35 0.5×	16 0.4×	17	491
Névéna Mollova United States	14	272 1.5×	78 0.7×	28 0.4×	14 0.2×	29 0.7×	39	478
Harold E. Osborne United States	9	217 1.2×	69 0.6×	71 1.0×	32 0.5×	25 0.6×	11	455
Bryan C. Duffy United States	10	134 0.7×	81 0.7×	67 1.0×	52 0.8×	17 0.4×	13	311
Theresa J. Roethke United States	11	139 0.8×	56 0.5×	23 0.3×	40 0.6×	33 0.8×	16	344
Simon J. Mantell United Kingdom	14	173 0.9×	149 1.3×	23 0.3×	64 0.9×	46 1.0×	18	357

Countries citing papers authored by Lisa E. Ranshaw

Since Specialization

Citations

This map shows the geographic impact of Lisa E. Ranshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Ranshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Ranshaw more than expected).

Fields of papers citing papers by Lisa E. Ranshaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa E. Ranshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Ranshaw. The network helps show where Lisa E. Ranshaw may publish in the future.

Co-authorship network of co-authors of Lisa E. Ranshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa E. Ranshaw. A scholar is included among the top collaborators of Lisa E. Ranshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa E. Ranshaw. Lisa E. Ranshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Flinders, Bryn, et al.. (2020). Monitoring the three‐dimensional distribution of endogenous species in the lungs by matrix‐assisted laser desorption/ionization mass spectrometry imaging. Rapid Communications in Mass Spectrometry. 35(1). e8957–e8957. 3 indexed citations

Flinders, Bryn, et al.. (2014). The use of hydrazine-based derivatization reagents for improved sensitivity and detection of carbonyl containing compounds using MALDI-MSI. Analytical and Bioanalytical Chemistry. 407(8). 2085–2094. 34 indexed citations

Tralau-Stewart, Cathy, Richard A. Williamson, Anthony T. Nials, et al.. (2011). GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization. Journal of Pharmacology and Experimental Therapeutics. 337(1). 145–154. 51 indexed citations

Nials, Anthony T., et al.. (2011). In Vivo Characterization of GSK256066, a High-Affinity Inhaled Phosphodiesterase 4 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 337(1). 137–144. 41 indexed citations

Woodrow, Michael D., Stuart P. Ballantine, Michael D. Barker, et al.. (2009). Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration. Bioorganic & Medicinal Chemistry Letters. 19(5). 1380–1385. 54 indexed citations

Judkins, Brian D., et al.. (2009). Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(1). 137–140. 29 indexed citations

Hamblin, J., Stuart P. Ballantine, Anthony W. J. Cooper, et al.. (2008). Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4237–4241. 59 indexed citations

Bamborough, Paul, Richard Angell, David Brown, et al.. (2007). N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: Indazoles as phenol isosteres with improved pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 17(15). 4363–4368. 39 indexed citations

Eddershaw, Peter, et al.. (1996). THE ALIPHATIC OXIDATION OF SALMETEROL TO α-HYDROXYSALMETEROL IN HUMAN LIVER MICROSOMES IS CATALYZED BY CYP3A. Drug Metabolism and Disposition. 24(5). 555–559.

10.

Manchee, Gary R., et al.. (1996). The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A.. PubMed. 24(5). 555–9. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact